Provided by Tiger Trade Technology Pte. Ltd.

Global X Genomics & Biotechnology ETF

66.92
+3.345.25%
Post-market: 66.920.00000.00%19:30 EDT
Volume:31.48K
Turnover:2.10M
Market Cap:100.70M
PE:- -
High:67.16
Open:65.16
Low:65.16
Close:63.58
52wk High:68.00
52wk Low:36.76
Shares:1.50M
Float Shares:1.50M
Volume Ratio:1.23
T/O Rate:2.09%
Dividend:0.65
Dividend Rate:0.97%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Milton Essex boosts Sanford Biotech capital to drive advanced mastitis cell therapy

TIPRANKS
·
Sep 08

The Second Act of Biotech

TIPRANKS
·
Sep 07

Insiders Shake Up Innovative, Alcoa, Illumina, Southern, Marathon

TIPRANKS
·
Sep 05

S&P 500 Quarterly Shake-Up: AI Demand Propels Bloom Energy Into the Index, Alongside Illumina and Everpure

Stock News
·
Sep 05

Bloom Energy, Illumina, and Everpure Set to Join S&P 500; Others to Join S&P 100, S&P MidCap 400, and S&P Smallcap 600

THOMSON REUTERS
·
Sep 05

Illumina Director Keith Meister Disposes of USD 30.51 Million in Common Shares

Reuters
·
Sep 05

Guardant announces FDA approval of Guardant360 CDx as companion diagnostic

TIPRANKS
·
Sep 05

Guardant Health Announces Landmark FDA Approval of Guardant360® Cdx as Companion Diagnostic for AstraZeneca’s Etcamah™ (Camizestrant) in Advanced Breast Cancer

THOMSON REUTERS
·
Sep 05

S&P Dow Jones Indices: Bloom Energy, Illumina, and Everpure Set to Join S&P 500

THOMSON REUTERS
·
Sep 05

Healthcare Stocks Pick up Steam as Investors Play Offense and Defense

Dow Jones
·
Sep 05

Dow Jones Top Company Headlines at 9 am ET: EQT to Buy Insurance Broker McGill in $2 Billion Deal | Tesla-Challenging ...

Dow Jones
·
Sep 04

Natera CEO Steven Leonard Chapman Disposes of 1,698 Common Shares for $545,441.02

Reuters
·
Sep 04

Moderna Chief Legal Officer Shannon Thyme Klinger Disposes of USD 485,271.45 in Common Shares

Reuters
·
Sep 04

Cboe data shows mixed options sentiment in Moderna with shares down 3.87%

TIPRANKS
·
Sep 04

Healthcare Stocks Pick up Steam as Investors Play Offense and Defense

Dow Jones
·
Sep 04

Why Moderna Stock's Cancer Vaccine Rally Sparked a Rare Sell Rating

Dow Jones
·
Sep 03

Rothschild & Co Redburn Downgrades Moderna to Sell From Neutral, Adjusts PT to $81 From $40

MT Newswires Live
·
Sep 03

Transgene Jumps 20% on Positive Cancer Vaccine Data in Early Trial

Reuters
·
Sep 03

uniQure seeks accelerated approval for Huntington’s gene therapy

TIPRANKS
·
Sep 02

uniQure Announces Submission of Biologics License Application for Ifezuntirgene Inilparvovec (AMT-130) in Huntington’s Disease

GlobeNewswire
·
Sep 02